Profile data is unavailable for this security.
About the company
RespireRx Pharmaceuticals Inc. develops treatments to combat disorders caused by disruption of neuronal signaling. The Company is developing treatment options that address conditions, such as obstructive sleep apnea (OSA), attention deficit hyperactivity disorder, epilepsy, acute and chronic pain, including inflammatory and neuropathic pain, and recovery from spinal cord injury (SCI), which are conditions that affect millions of people, as well as certain orphan disorders such as GRIA. It also considers developing treatment options for other conditions based on results of preclinical and clinical studies to date. The Company has two business units. ResolutionRx unit holds its pharmaceutical cannabinoids platform, and is developing compounds that target the body’s endocannabinoid system, and in particular, the re-purposing of dronabinol for the treatment of OSA. EndeavourRx is its neuromodulators platform, which is made up of two programs: AMPAkines program and GABAkines program.
- Revenue in USD (TTM)0.00
- Net income in USD-2.17m
- Incorporated1987
- Employees2.00
- LocationRespireRx Pharmaceuticals Inc126 Valley Rd Ste CGLEN ROCK 07452-1796United StatesUSA
- Phone+1 (201) 444-4947
- Fax+1 (302) 652-6760
- Websitehttp://www.respirerx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bespoke Extracts Inc | 785.45k | -1.48m | 833.31k | 10.00 | -- | -- | -- | 1.06 | -0.1458 | -0.1458 | 0.0774 | -0.1696 | 2.06 | 55.99 | 34.73 | 78,545.00 | -388.21 | -- | -- | -- | 43.69 | -- | -188.79 | -- | 0.0612 | -135.42 | -- | -- | 22,933.72 | -- | 63.98 | -- | -- | -- |
| Himalaya Technologies Inc | 0.00 | -629.85k | 914.88k | 2.00 | -- | -- | -- | -- | -0.003 | -0.003 | 0.00 | -0.002 | 0.00 | -- | -- | -- | -270.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -193.23 | -- | -- | -- |
| VG Life Sciences Inc | 0.00 | -4.30m | 1.05m | 7.00 | -- | -- | -- | -- | -0.0721 | -0.0721 | 0.00 | -0.0491 | 0.00 | -- | -- | -- | -384.41 | -294.08 | -- | -- | -- | -- | -- | -587,591.90 | -- | -1.70 | -- | -- | -- | -- | 16.58 | -- | -- | -- |
| Respirerx Pharmaceuticals Inc | 0.00 | -2.17m | 1.06m | 2.00 | -- | -- | -- | -- | -0.014 | -0.014 | 0.00 | -0.0412 | 0.00 | -- | -- | 0.00 | -2,255.78 | -2,491.69 | -- | -- | -- | -- | -- | -- | -- | -2.90 | -- | -- | -- | -- | -12.78 | -- | -- | -- |
| Herborium Group, Inc. | 340.33k | -318.65k | 1.09m | 2.00 | -- | -- | -- | 3.21 | -0.3492 | -0.3492 | 0.3672 | -1.16 | 2.32 | 3.89 | 25.94 | -- | -216.97 | -490.56 | -- | -- | 58.31 | 56.36 | -93.63 | -186.81 | 0.0331 | -39.14 | -- | -- | 19.45 | -18.15 | 120.44 | -- | -- | -- |
| Kaya Holdings Inc | 176.06k | 457.55k | 1.11m | 2.00 | 0.7846 | -- | 2.19 | 6.30 | 0.0637 | 0.0637 | 0.0028 | -0.6706 | 0.6613 | 14.24 | -- | 88,030.00 | 186.25 | 28.68 | -- | -- | 55.61 | 65.75 | 281.65 | 66.12 | 0.0161 | -- | -- | 0.00 | -71.36 | -29.62 | 145.01 | -19.45 | -- | -- |
| LadRx Corp | 0.00 | 1.66m | 1.11m | 2.00 | 0.6504 | 3.21 | 0.663 | -- | 3.44 | 3.44 | 0.00 | 0.6973 | 0.00 | -- | -- | 0.00 | 96.28 | -58.97 | -- | -78.44 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 106.96 | -- | -- | -- |
| Rimrock Gold Corp | 0.00 | -764.61k | 1.15m | 1.00 | -- | -- | -- | -- | -0.0104 | -0.0104 | 0.00 | -0.00008 | 0.00 | -- | -- | -- | -187.26 | -236.34 | -1,424.92 | -366.85 | -- | -- | -- | -83,418.52 | -- | -1.48 | 1.12 | -- | -- | -- | 30.55 | -- | -- | -- |
| Lucy Scientific Discovery Inc | 16.73k | -9.76m | 1.21m | -- | -- | 14.87 | -- | 72.15 | -6.34 | -7.21 | 0.0103 | 0.046 | 0.0037 | -- | 0.7276 | -- | -215.45 | -- | -- | -- | 49.97 | -- | -58,360.55 | -- | -- | -5.10 | 0.4615 | -- | -- | -- | -53.49 | -- | -- | -- |
| Vestiage Inc | 0.00 | -21.76k | 1.22m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0011 | 0.00 | -- | -- | -- | -4,945.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -102.30 | -- | -- | -- |
| Target Group Inc | 5.64m | 228.87k | 1.23m | 46.00 | 15.38 | -- | 1.16 | 0.2188 | 0.0001 | 0.0001 | 0.0088 | -0.0115 | 0.764 | 8.60 | 124.27 | 115,104.10 | 3.10 | -37.99 | -- | -78.76 | 43.71 | -- | 4.06 | -586.97 | 0.0736 | 0.0149 | 3.10 | -- | -- | 577.83 | 92.84 | -- | -58.54 | -- |
| PainReform Ltd | 0.00 | -12.54m | 1.23m | 6.00 | -- | 0.4995 | -- | -- | -7.77 | -7.77 | 0.00 | 0.9988 | 0.00 | -- | -- | 0.00 | -158.88 | -55.47 | -222.89 | -68.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.28 | -- | -- | -- |
| Actavia Life Sciences Inc | 0.00 | -406.65k | 1.23m | 1.00 | -- | -- | -- | -- | -0.0005 | -0.0005 | 0.00 | -0.0028 | 0.00 | -- | -- | 0.00 | -805.97 | -158.17 | -- | -- | -- | -- | -- | -- | -- | -5.63 | -- | -- | -- | -- | -547.04 | -- | -- | -- |
| GlobeStar Therapeutics Corp | 0.00 | -1.98m | 1.28m | -- | -- | -- | -- | -- | -0.0023 | -0.0023 | 0.00 | -0.0015 | 0.00 | -- | -- | -- | -38,103.72 | -4,657.88 | -- | -- | -- | -7,790.20 | -- | -2,834,410.00 | -- | -21.00 | -- | -- | -- | -- | -31.01 | -- | -- | -- |
